HASTE LIMITED
Company number 03440010 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: HASTE LIMITED
1. Financial Health Score: B+
Explanation: HASTE LIMITED is in robust overall health, demonstrating excellent cardiovascular strength through strong revenue growth and outstanding gross margins. The company has successfully rehabilitated its balance sheet from a state of negative equity in 2017 to a strong positive net asset position today. However, the score is kept from an 'A' due to symptoms of "cash flow congestion"—despite high profitability, the cash reserves have drained significantly, suggesting the business is bleeding working capital into trade debtors or capital investments.
2. Key Vital Signs
- Revenue (Energy Intake): £12.77 million (up from £10.64 million in 2023). The patient is consuming well, representing an approximate 20% year-over-year growth in top-line income.
- Gross Profit Margin (Metabolic Efficiency): 83.57% (up from 79.48%). This is an exceptionally efficient metabolism, indicating that the cost of delivering services is very low relative to the prices charged.
- Net Assets (Body Mass/Reserves): £1,546,562. This is a significant improvement from prior years. In 2017, the company had net assets of just £419,590. The patient has been building strong muscle and reserves.
- Cash Position (Blood Flow): £111,809. This is down substantially from £330,982 in 2023, and represents less than 1% of annual revenue. While not immediately fatal, this low blood pressure requires careful monitoring.
- Shareholders' Funds (Core Bone Density): £1,546,562. The equity foundation is solid and has grown by approximately £258,000 over the year, even after paying out £242,116 in dividends.
3. Diagnosis
Overall Condition: The patient is fundamentally healthy but experiencing acute working capital strain typical of rapid growth phases.
Symptoms Analysis: The most revealing symptom is the disparity between the income statement and the balance sheet. The business generated a healthy profit (evidenced by the growth in net assets and the ability to pay £242k in dividends), yet its cash reserves fell by over £219,000. This is a classic case of "cash flow congestion." The blood (cash) is trapped in the veins (trade debtors), rather than circulating back to the heart.
Alternatively, the company may be investing heavily in fixed assets to support its strategic pivot toward metering services and IT solutions. The financial statements note a focus on "expansion of its metering services" and providing "IT solutions necessary to remain in the metering section," which often requires upfront capital investment.
The company also exhibits a susceptibility to "arrhythmia" in its revenue streams. The strategic report highlights that non-metering work is reactive and driven by unpredictable electricity network faults. This fluctuating workload is a chronic condition that the directors are actively treating by seeking complementary services to stabilize the heartbeat.
4. Recommendations
To improve financial wellness and prevent future complications, the following interventions are recommended:
- Improve Circulation (Debtors Management): With cash dropping despite rising sales, the company must accelerate the collection of trade debtors. Implement stricter credit control procedures, shorten payment terms where possible, and consider offering early-payment discounts to clients to get cash back into the bloodstream faster.
- Monitor Blood Pressure (Cash Flow Forecasting): A cash reserve of £111k on £12.7m of revenue leaves very little margin for error. The business should build a 13-week rolling cash flow forecast to ensure it can meet payroll and supplier obligations during periods of low "reactive" work.
- Stabilize the Heartbeat (Revenue Diversification): Continue the prescribed treatment of expanding metering services. Contract-based, predictable metering work will act as a pacemaker, providing steady revenue to offset the erratic, fault-based non-metering work.
- Review Dividend Policy: While the company is profitable, paying out £242,116 in dividends during a period where cash reserves fell by £219,000 has strained the system. Future dividends should be more closely tied to actual cash generation rather than paper profits to preserve liquidity.